March 2026

ACC's new president | The fight for safer cath labs | The future of cardiovascular leadership | Focusing on women's health ()
New stroke prevention device for TAVR holds its own in late-breaking study | FDA clears AI model for pulmonary hypertension ()
Late-breaking data from ACC.26 | Thousands of insulin pumps recalled | Vascular surgeons make an impact | Voice-based AI tech ()
Week in Review: Celebrating young leaders | Death sentence confirmed for patient-killing nurse | New cath lab safety standards ()
Get to know the Cardiovascular Business 40 Under 40 | A historic stroke procedure | Healthcare costs are up—but not survival ()
FDA clears AI for M-TEER | Surgeon treats stroke from 120 miles away | Premature menopause, cold weather linked to major risks ()
A new use for an established device | When TAVR patients can’t wait | FDA-approved lead for LBBAP makes US debut ()
Trust in federal agencies is down | Fighting for better cath lab safety standards | New cholesterol recommendations ()
Cardiologists want new cath lab safety standards | Off-the-shelf conduit for CABG shows promise | A new AI partnership ()
News Alert: Cardiologists lead push for new cath lab safety standards ()
FDA approves tiny Medtronic lead for LBBA placement | A new business model | CV risks & cognitive function | Telehealth trends ()
FDA-approved valve makes US debut | Reviewing CRT 2026 | First TAVR of its kind uses crushed stent | 20-year PFO closure data ()
Meet the CVB 40 Under 40 | Another win for Wegovy | Key benefits of cardiovascular IT systems | New tirzepatide data | AI & IVUS ()
Top 10 most popular cardiology video interviews this past month ()
Week in Review: A historic TAVR approval | Death sentence confirmed for patient-killing nurse | Insulin delivery pods recalled ()
CMS targets cardiologists | AI turns wearable data into insights | Heart failure after PCI | Prior authorization reducing access ()
FDA clears next-gen insulin pump | Key issues in EP | New-look valve makes US debut | The benefits of morning exercise ()
New PE guidelines | FDA clears 'world's smallest camera' | Medtronic's $550M acquisition | J&J launches 3 stroke devices ()
FDA approves first TAVR system for AR | AKI after TAVR | Injection could heal heart attack damage | Ultra-processed foods ()
News Alert: FDA approves first TAVR system for aortic regurgitation ()
AI gets value out of wearable data | Death sentence confirmed for patient-killing nurse | Tributes to a pioneer cardiologist ()
AI's growing influence in cardiology | New heart failure implant shows potential | FDA clears advanced technologies ()
Heart failure after PCI | Obesity stats highlight value of prevention | Trump's EPA proposes big changes | Key Heartflow updates ()
Vascular imaging at heart of $71M fraud scheme | It’s getting harder to see a cardiologist | Did you make the list? ()
Practice pays $4.75M to resolve fraud allegations | Insulin pods recalled | Takeaways from CRT 2026 | Dyslipidemia guidelines ()
Week in Review: Medtronic makes a move | Key details about catheter recall | Cardiology a leader in AI | Oversizing during TAVR ()
Key FDA approvals | Radiation during heart scans | Whole-body MRI provider offers AI-powered CCTA | 3D echo & CHD ()
Cardiologists & AI policies | FDA clears ‘world’s smallest camera’ | Prior authorization doing harm | Comparing DOACs ()
Faster coronary IVL catheter impresses | CCTA now an essential tool | Treating ‘no-option’ chest pain patients | RDN updates ()
Radiotracer shortage winding down | FDA clears new catheter | The high costs of healthcare | Vascular surgeons deliver value ()
TAVR Highlights: A new implantation technique | The world's first polymeric valve | Planning ahead | Oversizing boosts survival ()
Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons ()
Cardiologist develops new heart device | FDA approves pacing lead for LBBAP | A warning about universal screening ()
News Alert: Medtronic announces $550M acquisition ()
Looking ahead to ACC.26 | Oversizing during TAVR boosts survival | Next-generation device delivers | AATS wants better research ()
Cardiology still a leader in AI | FDA details catheter recall | A key approval for Philips | Potential new gene therapies ()
Week in Review: FDA approves next-generation device | More recalls for Impella heart pumps | CMS targets cardiologists ()
News Alert: FDA warns public about reprocessed catheter recalls ()
World’s first polymeric TAVR valve | Cardiologists develop new AI tool | High-sensitivity troponin | Heart issues in infants ()
Experimental pill could be a game-changer | Device error linked to 114 injuries | Statin labels need an update | A $1M donation ()
AI-enabled HF implant impresses | Cardiologist lied about penile cancer | How to talk about GLP-1 drugs | Risks after T-TEER ()
SAVR linked to ‘excellent’ long-term survival | A new cardiac care certification | AI for congenital heart disease ()
CMS targets cardiologists for payment model | The first TAVR of its kind | AI has a long way to go | PFA tech gains new approval ()
February's Top Stories: Multiple recalls | Statin labeling needs to be revised | A new device for AFib patients | TAVR vs. SAVR ()
FDA confirms heart pump recalls | Federal funding for PAD | Recreational Adderall | New stroke devices | Ultrasound RDN in Japan ()
News Alert: FDA confirms more recalls for Johnson & Johnson heart pumps ()
FDA approves next-gen HF device | Inconsistent radiation doses | Treating ‘no-option’ patients | New GLP-1 data | CHD risks ()